<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72170">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01884142</url>
  </required_header>
  <id_info>
    <org_study_id>Ergoreflex</org_study_id>
    <nct_id>NCT01884142</nct_id>
  </id_info>
  <brief_title>Effects of Exercise Training on Mechanoreflex and Metaboreflex Control in Heart Failure Patients</brief_title>
  <official_title>Effects of Exercise Training on Mechanoreflex and Metaboreflex Control of Muscle Sympathetic Nerve Activity in Heart Failure Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <authority>Brazil: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that exercise training would improve the mechanoreflex and
      metaboreflex control  in heart failure patients.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Autonomic Control</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mechanoreceptors were activated by passive exercise and metaboreceptors by post-exercise circulatory arrest</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscular Evaluation</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Muscular evaluation will be done by muscle gene expression</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Capacity</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Functional Capacity will be determined by cardiopulmonary exercise testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle Blood Flow</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Forearm blood flow will be assessed by venous occlusion plethysmography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Blood pressure will be monitored non-invasively</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Heart Failure Untrained Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control Group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heart Failure Exercise-trained Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aerobic Exercise Training</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic Exercise Training</intervention_name>
    <arm_group_label>Heart Failure Exercise-trained Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with systolic heart failure;

          -  New York Heart Association (NYHA) class II-III;

          -  Left ventricular ejection fraction less than 40%;

          -  Peak Oxygen Consumption less than 20 ml/Kg/min;

          -  Stable Clinical Status.

        Exclusion Criteria:

          -  Chronic Obstructive Pulmonary Disease;

          -  Neuromuscular Diseases;

          -  Orthopedic Diseases;

          -  Neurologic Diseases;

          -  Neoplastic Diseases;

          -  Recent myocardial infarction or cardiac surgery (less than 6 months);

          -  Unstable angina pectoris;

          -  Atrial Fibrillation;

          -  Pacemakers users;

          -  Changing medication or hospital admission.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos E Negrão, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heart Institute (InCor), University of Sao Paulo Medical School</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-904</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>September 5, 2013</lastchanged_date>
  <firstreceived_date>March 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>Lígia M. Antunes-Correa</investigator_full_name>
    <investigator_title>PhD student</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
